November 17th, 2026White House pulls Overton FDA nomination, Marshall might be nominated insteadHeidi Overton ran into opposition from Republican senators concerned about her role in setting White House vaccine policy.Read more
November 17th, 2026Takeda launches Orzeyful, first orexin agonist for narcolepsy type 1Takeda’s Orzeyful, the first orexin agonist for narcolepsy type 1, is now available in the U.S. at a whole acquisition list price of $16,500 per 60-tablet bottle.Read more
November 17th, 2026From Keytruda biosimilar to novel ADC: Samsung Bioepis’ 2-track oncology strategySBE303, a Nectin-4 ADC for previously treated bladder cancer, is in phase 1 as the company advances SB27, its proposed Keytruda biosimilar.Read more